Related resources
Full-text held externally
Search for item elsewhere
University researcher(s)
Academic department(s)
The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: An 11C-(R)PK11195 PET Imaging and Neuropathology Study
Su, Z; Roncaroli, F; Durrenberger, P F; Coope, D J; Karabatsou, K; Hinz, R; Thompson, G; Turkheimer, F E; Janczar, K; Du Plessis, D; Brodbelt, A; Jackson, A; Gerhard, A; Herholz, K
J Nucl Med. 2015;56(4):512-7.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
Abstract
The 18-kDa mitochondrial translocator protein (TSPO) is upregulated in high-grade astrocytomas and can be imaged by PET using the selective radiotracer (11)C-(R)PK11195. We investigated (11)C-(R)PK11195 binding in human gliomas and its relationship with TSPO expression in tumor tissue and glioma-associated microglia/macrophages (GAMs) within the tumors. METHODS: Twenty-two glioma patients underwent dynamic (11)C-(R)PK11195 PET scans and perfusion MR imaging acquisition. Parametric maps of (11)C-(R)PK11195 binding potential (BPND) were generated. Coregistered MR/PET images were used to guide tumor biopsy. The tumor tissue was quantitatively assessed for TSPO expression and infiltration of GAMs using immunohistochemistry and double immunofluorescence. The imaging and histopathologic parameters were compared among different histotypes and grades and correlated with each other. RESULTS: BPND of (11)C-(R)PK11195 in high-grade gliomas was significantly higher than in low-grade astrocytomas and low-grade oligodendrogliomas. TSPO in gliomas was expressed predominantly by neoplastic cells, and its expression correlated positively with BPND in the tumors. GAMs only partially contributed to the overall TSPO expression within the tumors, and TSPO expression in GAMs did not correlate with tumor BPND. CONCLUSION: PET with (11)C-(R)PK11195 in human gliomas predominantly reflects TSPO expression in tumor cells. It therefore has the potential to effectively stratify patients who are suitable for TSPO-targeted treatment.
Bibliographic metadata
- Related website http://www.ncbi.nlm.nih.gov/pubmed/25722450
- Su, Zhangjie Roncaroli, Federico Durrenberger, Pascal F Coope, David J Karabatsou, Konstantina Hinz, Rainer Thompson, Gerard Turkheimer, Federico E Janczar, Karolina Du Plessis, Daniel Brodbelt, Andrew Jackson, Alan Gerhard, Alexander Herholz, Karl United States Journal of nuclear medicine : official publication, Society of Nuclear Medicine J Nucl Med. 2015 Apr;56(4):512-7. doi: 10.2967/jnumed.114.151621. Epub 2015 Feb 26.